RNIB requires wet AMD patients for research

Article

The Royal National Institute of the Blind (RNIB) require 300 patients and carers to participate in two research projects.

The Royal National Institute of the Blind (RNIB) require 300 patients and carers to participate in two research projects.

They need 100 wet AMD patients, 100 carers of people with wet AMD and 100 patients with cataract. The aim of the research is to assess the impact of restrictions on treatment access and to ask eye health specialists how their services are delivered.

Patients must have been diagnosed and treated for either wet AMD or cataracts in the last three years. This can include those who are still undergoing treatment or have completed it.

Research will be conducted confidentially over the telephone and reports will be published in Spring 2013. The results will enable the RNIB to campaign for primary care trusts to alter their policies and improve treatment access.

To enter patients who are interested in taking part please email campaigns@rnib.org.uk by Friday 14th December 2012.

For further information visit the website.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.